Vistakon® Introduces New 1-day Acuvue® Trueye® Brand Contact Lenses (Narafilcon A) in U.S.

U.S. Upgraded to Global Standard of Popular Daily Disposable Brand

JACKSONVILLE, Fla. (March 28, 2013) – VISTAKON® Division of Johnson & Johnson Vision Care, Inc., today announced the U.S. introduction of 1-DAY ACUVUE® TruEye® Brand Contact Lenses (narafilcon A), a silicone hydrogel daily disposable lens currently being enjoyed by over 1.3 million patients worldwide. 1-DAY ACUVUE® TruEye® Brand (narafilcon A) is now available at some U.S. Eye Care Professionals’ offices, with distribution expected to grow throughout the coming months.

Developed with today’s contact lens wearer in mind, 1-DAY ACUVUE® TruEye® (narafilcon A) is designed to help maintain the natural ocular environment, offering a distinctive balance of properties that enables it to offer exceptional comfort, comparable to a contact lens-free eye. “1-DAY ACUVUE® TruEye® was designed, developed, and clinically researched versus the ultimate benchmark: the natural eye,” says Dick Wallingford, O.D., Senior Director, Professional Affairs, VISTAKON®.

The lens features HYDRACLEAR®1 Technology, which attracts tear film to help maintain the natural ocular environment for all-day comfort; High O2 Consumption, allowing 100 percent corneal oxygen consumption at all points across minus and plus powers for white, healthy-looking eyes, and Class-1

UV-Blocking, offering patients the highest level of UV protection in a contact lens, blocking approximately 96 percent of UV-A rays and greater than 99 percent of UV-B rays that reach the lens.† **

1-DAY ACUVUE® TruEye® Brand Contact Lenses (narafilcon A) will gradually replace 1-DAY ACUVUE® TruEye® (narafilcon B), which was launched in the U.S. in 2010. “The narafilcon B product was only being utilized in the U.S and a few Caribbean countries, while the narafilcon A product, launched in 2008, has become the global standard throughout Europe, Japan, and other markets,” explains VISTAKON® president Dave Brown. “We believe we will better be able to serve the needs of our customers around the world by having one version of this breakthrough product.”

A majority of the material properties of 1-DAY ACUVUE® TruEye® (narafilcon A) are similar to the narafilcon B product, “but they are different products,” says Dr. Wallingford. One key difference is that 1-DAY ACUVUE® TruEye® (narafilcon A) is available in two base curves (8.5 and 9.0) allowing more patients to be fit with this lens. “In a clinical trial of current 1-DAY ACUVUE® TruEye® (narafilcon B) lens wearers, 99 percent of subjects were evaluated to have an acceptable lens fit with 1-DAY ACUVUE® TruEye® Brand Contact Lenses (narafilcon A),” he notes. “In addition, 1-DAY ACUVUE® TruEye® (narafilcon A) has a DK/t of 118 for increased oxygen transmissibility with virtually no impact to modulus.

1-DAY ACUVUE® TruEye® (narafilcon A) will only be available in 90-packs.”Research shows that 95 percent of 1-DAY ACUVUE® TruEye® patients currently purchase 90-packs,” notes Brown.

According to VISTAKON®, there will be a finite amount of time in which both the narafilcon A and narafilcon B products will be available in the U.S.

“Our aim is to quickly transition to 1-DAY ACUVUE® TruEye® (narafilcon A), and we will provide doctors with a number of tools to help smooth the conversion process for eye care professionals and patients,” notes Brown. “We are confident that 1-DAY ACUVUE® TruEye® (narafilcon A) will help doctors make more patients happy, and drive additional patient referrals – the key to practice growth.”

Information about 1-DAY ACUVUE® TruEye® (narafilcon A) is available by calling the company’s customer service team at 1-800-874-5278.

ACUVUE® Brand Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. Consult the package insert for complete information. Complete information is also available from VISTAKON® Division of Johnson & Johnson Vision Care, Inc., by calling 1-800-843-2020 or by visiting

† Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

* *WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-Blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-Blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

  • <<
  • >>